학술논문

Combined Assessment of GCase Activity and α-synuclein as a Promising Blood Biomarker for GBA Mutation Carriers.
Document Type
Article
Source
Parkinsonism & Related Disorders. May2024, Vol. 122, pN.PAG-N.PAG. 1p.
Subject
*ALPHA-synuclein
*BIOMARKERS
*GENETIC mutation
Language
ISSN
1353-8020